201 related articles for article (PubMed ID: 37884213)
1. Lyotropic liquid crystalline phases: Drug delivery and biomedical applications.
Chavda VP; Dyawanapelly S; Dawre S; Ferreira-Faria I; Bezbaruah R; Rani Gogoi N; Kolimi P; Dave DJ; Paiva-Santos AC; Vora LK
Int J Pharm; 2023 Nov; 647():123546. PubMed ID: 37884213
[TBL] [Abstract][Full Text] [Related]
2. Lyotropic Liquid Crystalline Nanostructures as Drug Delivery Systems and Vaccine Platforms.
Chountoulesi M; Pispas S; Tseti IK; Demetzos C
Pharmaceuticals (Basel); 2022 Mar; 15(4):. PubMed ID: 35455426
[TBL] [Abstract][Full Text] [Related]
3. Non-Lamellar Lyotropic Liquid Crystalline Lipid Nanoparticles for the Next Generation of Nanomedicine.
Zhai J; Fong C; Tran N; Drummond CJ
ACS Nano; 2019 Jun; 13(6):6178-6206. PubMed ID: 31082192
[TBL] [Abstract][Full Text] [Related]
4. Oral and transdermal drug delivery systems: role of lipid-based lyotropic liquid crystals.
Rajabalaya R; Musa MN; Kifli N; David SR
Drug Des Devel Ther; 2017; 11():393-406. PubMed ID: 28243062
[TBL] [Abstract][Full Text] [Related]
5. Controlling molecular transport and sustained drug release in lipid-based liquid crystalline mesophases.
Zabara A; Mezzenga R
J Control Release; 2014 Aug; 188():31-43. PubMed ID: 24910192
[TBL] [Abstract][Full Text] [Related]
6. Nanostructured cubosomes as advanced drug delivery system.
Pan X; Han K; Peng X; Yang Z; Qin L; Zhu C; Huang X; Shi X; Dian L; Lu M; Wu C
Curr Pharm Des; 2013; 19(35):6290-7. PubMed ID: 23470001
[TBL] [Abstract][Full Text] [Related]
7. Phytantriol based smart nano-carriers for drug delivery applications.
Akbar S; Anwar A; Ayish A; Elliott JM; Squires AM
Eur J Pharm Sci; 2017 Apr; 101():31-42. PubMed ID: 28137471
[TBL] [Abstract][Full Text] [Related]
8. Lyotropic liquid crystals for parenteral drug delivery.
Chavda VP; Dawre S; Pandya A; Vora LK; Modh DH; Shah V; Dave DJ; Patravale V
J Control Release; 2022 Sep; 349():533-549. PubMed ID: 35792188
[TBL] [Abstract][Full Text] [Related]
9. Liquid Crystalline Phases for Enhancement of Oral Bioavailability.
Zhang X; Wu W
AAPS PharmSciTech; 2021 Feb; 22(3):81. PubMed ID: 33619612
[TBL] [Abstract][Full Text] [Related]
10. Bioimaging Applications of Non-Lamellar Liquid Crystalline Nanoparticles.
Murgia S; Biffi S; Fornasier M; Lippolis V; Picci G; Caltagirone C
J Nanosci Nanotechnol; 2021 May; 21(5):2742-2759. PubMed ID: 33653441
[TBL] [Abstract][Full Text] [Related]
11. Lipid polymorphism in lyotropic liquid crystals for triggered release of bioactives.
Garti N; Libster D; Aserin A
Food Funct; 2012 Jul; 3(7):700-13. PubMed ID: 22592749
[TBL] [Abstract][Full Text] [Related]
12. Cubic and hexagonal liquid crystals as drug delivery systems.
Chen Y; Ma P; Gui S
Biomed Res Int; 2014; 2014():815981. PubMed ID: 24995330
[TBL] [Abstract][Full Text] [Related]
13. Cubic lyotropic liquid crystals as drug delivery carriers: Physicochemical and morphological studies.
Chountoulesi M; Pippa N; Pispas S; Chrysina ED; Forys A; Trzebicka B; Demetzos C
Int J Pharm; 2018 Oct; 550(1-2):57-70. PubMed ID: 30121331
[TBL] [Abstract][Full Text] [Related]
14. Lyotropic liquid crystal systems in drug delivery.
Guo C; Wang J; Cao F; Lee RJ; Zhai G
Drug Discov Today; 2010 Dec; 15(23-24):1032-40. PubMed ID: 20934534
[TBL] [Abstract][Full Text] [Related]
15. Recent patents on nonlamellar liquid crystalline lipid phases in drug delivery.
Koynova R; Tenchov B
Recent Pat Drug Deliv Formul; 2013 Dec; 7(3):165-73. PubMed ID: 23829393
[TBL] [Abstract][Full Text] [Related]
16. Glycerol monooleate liquid crystalline phases used in drug delivery systems.
Milak S; Zimmer A
Int J Pharm; 2015 Jan; 478(2):569-87. PubMed ID: 25479099
[TBL] [Abstract][Full Text] [Related]
17. Cubosomes as an emerging platform for drug delivery: a review of the state of the art.
Abourehab MAS; Ansari MJ; Singh A; Hassan A; Abdelgawad MA; Shrivastav P; Abualsoud BM; Amaral LS; Pramanik S
J Mater Chem B; 2022 Apr; 10(15):2781-2819. PubMed ID: 35315858
[TBL] [Abstract][Full Text] [Related]
18. Novel steric stabilizers for lyotropic liquid crystalline nanoparticles: PEGylated-phytanyl copolymers.
Chong JY; Mulet X; Keddie DJ; Waddington L; Mudie ST; Boyd BJ; Drummond CJ
Langmuir; 2015 Mar; 31(9):2615-29. PubMed ID: 25068381
[TBL] [Abstract][Full Text] [Related]
19. Self-assembled multicompartment liquid crystalline lipid carriers for protein, peptide, and nucleic acid drug delivery.
Angelova A; Angelov B; Mutafchieva R; Lesieur S; Couvreur P
Acc Chem Res; 2011 Feb; 44(2):147-56. PubMed ID: 21189042
[TBL] [Abstract][Full Text] [Related]
20. [Advances in the study of lipid-based cubic liquid crystalline nanoparticles as drug delivery system].
Wu HB; Huo DF; Jiang XG
Yao Xue Xue Bao; 2008 May; 43(5):450-5. PubMed ID: 18717329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]